50.58
0.00 (0.00%)
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eidos Therapeutics Inc | EIDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 1.58 | 3.22% | 50.58 | 46.39 | 50.83 | 47.59 | 49.00 | 18:00:56 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 15.00 | 62.02 | 47.02 | 75.81% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,454 | 85,899 | $ 49.18 | $ 4,224,239 | 106,708 | 16.75 - 66.5587 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:54:16 | formt | 604 | $ 50.58 | USD |
Eidos Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 1.90B | 37.50M | $ -40.73M | -1.95 | - | 37.04M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Eidos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EIDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 54.07 | 54.07 | 44.30 | 49.30 | 92,554 | -3.49 | -6.45% |
| 1 Month | 52.77 | 56.47 | 44.30 | 52.77 | 117,047 | -2.19 | -4.15% |
| 3 Months | 58.25 | 66.5587 | 44.30 | 57.05 | 118,950 | -7.67 | -13.17% |
| 6 Months | 45.17 | 66.5587 | 33.34 | 49.54 | 154,269 | 5.41 | 11.98% |
| 1 Year | 19.35 | 66.5587 | 16.75 | 39.32 | 159,584 | 31.23 | 161.4% |
| 3 Years | 20.00 | 66.5587 | 8.89 | 29.42 | 163,427 | 30.58 | 152.9% |
| 5 Years | 20.00 | 66.5587 | 8.89 | 29.42 | 163,427 | 30.58 | 152.9% |
Eidos Therapeutics Description
| Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins. |
